Latest News about LLY
Recent news which mentions LLY
From Benzinga
3 No-Brainer Stocks to Buy Right Now
October 14, 2021
From Motley Fool
The Daily Biotech Pulse: FDA Nod For Lilly, Regulus Slumps On Study Discontinuation, ObSeva Strikes Linzagolix Commercialization Deal
October 13, 2021
From Benzinga
AstraZeneca's COVID-19 Therapy Hits Goal In Phase 3 Trial
October 11, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2021
October 11, 2021
From Benzinga
10 Biggest Price Target Changes For Monday
October 11, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 10-16): Avadel FDA Decision, Conference Presentations And IPOs Take Center Stage
October 10, 2021
From Benzinga
From Motley Fool
Why AbCellera Biologics Stock Jumped 19.4% Last Month
October 07, 2021
From Motley Fool
From Benzinga
Eli Lilly Stock: Buy on the Dip?
October 05, 2021
From Motley Fool
2 Leading Healthcare Stocks to Buy in 2021 and Beyond
October 02, 2021
From Motley Fool
Location, location, location: Ohio is benefiting in tech growth as a major transportation hub
October 02, 2021
From MarketWatch
From MarketWatch
Eli Lilly's Mirikizumab Maintains Symptomatic Remission for Two Years In Ulcerative Colitis Patients
October 01, 2021
Tickers
LLY
From Benzinga
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
September 30, 2021
From Benzinga
Eli Lilly Shares Positive Tirzepatide Data At EASD Annual Meeting
September 30, 2021
Tickers
LLY
From Benzinga
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
September 30, 2021
From Motley Fool
Citi Upgrades This Big Pharma Stock On Positive Alzheimer's Expectations
September 29, 2021
Tickers
LLY
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2021
September 29, 2021
From Benzinga
FDA Expands Lilly's Erbitux Label For Colorectal Cancer Setting
September 29, 2021
From Benzinga
The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug
September 29, 2021
From Benzinga
10 Biggest Price Target Changes For Wednesday
September 29, 2021
From Benzinga
7 Biotech Stocks Entering the Golden Boom Phase
September 28, 2021
From InvestorPlace
3 Growth Stocks That Can Help You Retire Early
September 28, 2021
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.